Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 10, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	66	77	130	61	92	270
Market Cap Growth	-37.12%	-40.82%	111.36%	-33.17%	-66.08%	60.46%
Enterprise Value	50	47	108	25	68	237
Last Close Price	0.79	0.98	1.86	0.88	1.65	5.11
PB Ratio	6.43	4.01	24.95	2.08	4.40	7.09
P/TBV Ratio	6.47	4.03	25.23	2.08	4.42	7.10
Debt / Equity Ratio	0.02	0.01	-	-	-	0.00
Net Debt / Equity Ratio	-1.52	-1.29	-3.27	-1.14	-0.99	-1.06
Net Debt / EBITDA Ratio	0.72	1.21	0.91	2.06	0.92	2.33
Net Debt / FCF Ratio	0.92	1.49	1.04	2.65	0.87	2.64
Quick Ratio	3.82	6.21	6.34	4.95	8.33	9.93
Current Ratio	4.01	6.35	6.66	5.23	8.92	10.26
Return on Equity (ROE)	-91.21%	-97.22%	-146.88%	-39.94%	-76.56%	-46.54%
Return on Assets (ROA)	-53.51%	-53.68%	-42.00%	-34.02%	-42.75%	-27.10%
Return on Capital Employed (ROCE)	-160.60%	-85.20%	-114.80%	-55.30%	-107.90%	-45.60%
Earnings Yield	-20.96%	-15.40%	-19.66%	-16.40%	-24.62%	-6.40%
FCF Yield	-	-21.56%	-12.55%	-20.65%	-25.72%	-5.66%
Buyback Yield / Dilution	-11.18%	-10.10%	-7.57%	-19.25%	-9.31%	-55.68%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.